Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ying Tan has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrated proteomic and single-nucleus transcriptomic profiling identifies prognostic markers and therapeutic targets in glioblastoma

    by Chengyong Yang, Junchi Luo, Sha Yang, Mei Deng, Tao Xiong, Junheng Zhang, Wenjing Yang, Jiqin Zhang, Xin Xiang, Liangzhao Chu, et al.

    Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults and remains associated with marked heterogeneity and poor prognosis. To identify prognostic biomarkers and characterize their cellular contexts, we integrated public proteomic and single-nucleus transcriptomic datasets. Protein expression data from the TCPA GBM cohort were used to construct a prognostic model by univariate and multivariable Cox regression analyses, followed by Kaplan-Meier survival, time-dependent ROC, and nomogram analyses. Single-nucleus RNA-seq data from GSE138794 were used to define the cellular distribution of model proteins and to perform marker-centered functional analyses. A four-protein signature consisting of BCL2, CTNNB1, CHEK2, and NDRG1_pT346 was established. The derived risk score significantly stratified patients into high- and low-risk groups with distinct overall survival and progression-free survival outcomes, and remained independently associated with prognosis after adjustment for clinical covariates. In the single-cell atlas, inferCNV-guided refinement identified malignant glioma cells and further resolved them into Glioma_MES, Glioma_PN, and Glioma_CL states. The four prognostic markers showed distinct cellular preferences: BCL2 and NDRG1 were mainly enriched in oligodendroglial-related populations and selected glioma states, whereas CHEK2 and CTNNB1 were more highly expressed in myeloid-associated populations. Among the four markers, only CHEK2- and NDRG1-defined malignant glioma subgroups showed sufficient transcriptional divergence for downstream analysis. CHEK2-positive glioma cells were enriched for DNA replication, chromosome segregation, DNA damage response, and checkpoint-related programs, whereas NDRG1-positive glioma cells were characterized by hypoxia response, glycolysis, and metabolic adaptation. CellChat analysis further revealed distinct communication patterns for CHEK2- and NDRG1-associated malignant glioma cells.

  • Open Access

    Cell type resolved MR based on brain single cell eQTLs corroborated by single cell RNA sequencing uncovers neuroimmune and vascular programs in intracerebral hemorrhage

    by Sha Yang, Xiangqian Ren, Mei Deng, Junchi Luo, Guoqiang Han, Tao Xiong, Tao Luo, Jiqin Zhang, Ying Tan, Yunjia Hu

    Intracerebral hemorrhage (ICH) lacks effective neuroprotective therapies. We integrated cell type–resolved genetic inference with single-cell profili

  • Open Access

    Role of BMEC‐Derived Exosomal miR‐144‐3p in Microglial Polarization: Unveiling the NLRP3‐GSDMD Pathway in Intracerebral Hemorrhage

    by Jun Ma, Zhongying Ran, Tao Luo, Zexin Jin, Ying Tan, Hao Yin

    Background: Intracerebral hemorrhage (ICH) often triggers a cascade of inflammatory responses, leading to secondary brain injury. The present work elucidated the regulatory mechanisms of NLRP3 inflammasome pathway activation in exosomal vesicle secretion by brain microvascular endothelial cells (BMECs)‐derived exosomes and its influence on the polarization and recruitment of microglial cells (GCs). Methods: In an in vitro model, BMECs were pretreated with hemin to mimic the ICH environment and then cocultured with GCs in a replaced medium. NLRP3 inhibitor MCC950 and exosome release inhibitor GW4869 were used to observe the effects of NLRP3 inflammation and exosomes in BMECs. Gene expression was detected using western blotting (WB), immunofluorescence (IF), and real‐time quantitative PCR. M1 polarization and migration of GCs were evaluated using biomarker expression, flow cytometry, and Transwell assays. The cellular mechanisms were further explored using an in vivo ICH rat model. Results: Hemin pretreatment activated NLRP3 inflammasomes and upregulated gasdermin D (GSDMD‐N) production in BMECs, which further contributed to enhanced migration and M1 polarization of cocultured GCs. MCC950 and GW4869 significantly inhibited the effects of BMECs on GCs migration and M1 polarization. Mechanically, the NLRP3/GSDMD pathway promoted the release of exosomes from BMECs, which were absorbed by GCs and resulted in changes in their migration ability and polarization. Furthermore, miR‐144‐3p was identified as an important regulator in BMEC‐derived exosomes and mediated the effect of BMECs on GSDMD. Knockdown of GSDMD in BMECs weakened the enhanced migration and M1 polarization of GCs by inhibiting the release of BMEC‐derived exosomes, while miR‐144‐3p overexpression in GCs abolished these effects. An in vivo study illustrated that MCC950 decreased pro‐inflammatory cytokine and CD86 levels, which were recovered by miR‐144‐3p overexpressing adeno‐associated virus (AAV) injection. Conclusions: This investigation revealed that the NLRP3/GSDMD pathway promotes the secretion of BMEC‐derived exosomes, which transfer miR‐144‐3p from BMECs to GCs, further inducing the migration and M1 polarization of GCs.

  • Open Access

    Osteopontin inhibitor alleviates neuroinflammation after subarachnoid hemorrhage in rats via TLR4/NF-κB pathway

    by Dexun Kong, Jing Guo, Sha Yang, Xiang Wang, Qihui Guo, Xiangqian Ren, Jiqin Zhang, Hao Yin, Xin Xiang, Ying Tan


  • Global burden of disease study highlights the global, regional and national trends of stroke

    by Sha Yang, Mei Deng, Xiangqian Ren, Fang Wang, Zhuo Kong, Junchi Luo, Yalin Cao, Guoqiang Han, Hao Yin, Xin Xiang, et al.

    Background Stroke remains a significant global health challenge, especially in low- and middle-income countries, despite advances in treatment and prevention. Understanding stroke trends is crucial for guiding prevention and healthcare strategies. Methods We analysed global data from the Global Burden of Disease Study 2021 on stroke incidence, prevalence, disability-adjusted life years and mortality from 1990 to 2021. The study focused on the major subtypes of stroke—ischaemic stroke (IS), intracerebral haemorrhage and subarachnoid haemorrhage—examining the effects of age, sex and sociodemographic index (SDI) on stroke outcomes. Decomposition analysis assessed the contributions of population growth, ageing and other factors to stroke burden. The Nordpred Prediction Model was used to forecast stroke trends from 2022 to 2046. Results From 1990 to 2021, global stroke incidence and deaths increased by 70.20% and 32.17%, respectively, driven by population ageing (45.3%) and growth (29.1%). However, age-standardised incidence and mortality rates declined by 21.78% and 39.10%, reflecting improvements in healthcare and risk factor control. IS saw the largest increase in crude incidence (87.97%), with regional disparities, especially in low-SDI countries. By 2046, global stroke incidence and mortality are projected to rise by 20.3% and 35.7%, primarily in low- and middle-SDI countries. Conclusions The global stroke burden is rising, particularly in low-SDI regions, due to ageing and population growth. Declines in age-standardised rates emphasise the importance of healthcare improvements. Region-specific strategies are needed to address the rising burden and reduce disparities in stroke outcomes.


  • Open Access

    Development and validation of nomogram model predicting overall survival and cancer specific survival in glioblastoma patients

    by Yingming Mu, Junchi Luo, Tao Xiong, Junheng Zhang, Jinhai Lan, Jiqin Zhang, Ying Tan, Sha Yang

    Background Identifying the incidence and risk factors of Glioblastoma (GBM) and establishing effective predictive models will benefit the management of these patients. Methods Using GBM data from the Surveillance, Epidemiology, and End Results (SEER) database, we used Joinpoint software to assess trends in GBM incidence across populations of different age groups. Subsequently, we identified important prognostic factors by stepwise regression and multivariate Cox regression analysis, and established a Nomogram mathematical model. COX regression model combined with restricted cubic splines (RCS) model was used to analyze the relationship between tumor size and prognosis of GBM patients. Results The incidence of GBM has been on the rise since 1978, especially in the age group of 65–84 years. 11498 patients with GBM were included in our study. The multivariate Cox analysis revealed that age, tumor size, sex, primary tumor site, laterality, number of primary tumors, surgery, chemotherapy, radiotherapy, systematic therapy, marital status, median household income, first malignant primary indicator were independent prognostic factors of overall survival (OS) for GBMs. For cancer-specific survival (CSS), race is also independent prognostic factors. Additionally, risk of poor prognosis increased significantly with tumor size in patients with tumors smaller than 49 mm. Moreover, our nomogram model showed favorable discriminative ability. Conclusion At the population level, the incidence of GBM is on the rise. The relationship between tumor size and patient prognosis is still worthy of further study. Moreover, the proposed nomogram with good performance was constructed and verified to predict the OS and CSS of patients with GBM.


  • Jugular Vein Evans Blue Injection for Blood–Brain Barrier Assessment Following Hemorrhagic Stroke in a Mouse Model

    by Yu Zeng, Fang Wang, Rui Liu, Jian Liu, Tao Xiong, Guodong Liu, Hao Yin, Guoqiang Han, Jiqin Zhang, Ying Tan

    The blood–brain barrier (BBB) is a selectively permeable membrane that plays a crucial role in protecting the brain from harmful substances. Its disruption is associated with various central nervous system (CNS) disorders, including hemorrhagic stroke. Evans Blue (EB) dye, a protein-binding tracer, is commonly used to assess BBB permeability. However, the method of injection significantly influences the accuracy and reproducibility of experimental results in the C57/6 mice. In this study, we evaluated the effectiveness of jugular vein injection of EB dye for assessing BBB integrity in a mouse intracerebral hemorrhage (ICH) model. This study investigates the efficacy of jugular vein injection of EB dye for assessing BBB integrity in C57/6 mice with ICH. Neurological deficits were assessed using the Longa and Modified Garcia Scales (GS) on day 1 post-ICH to ensure baseline consistency. Mice were anesthetized and injected with a 2% EB solution via either the jugular or tail vein. Only mice with successful tail vein injections were included in the tail vein injection group. The jugular vein injection method was successfully applied to all animals in the respective group. Plasma and brain EB concentrations were quantified by spectrophotometry following the processing of plasma and brain homogenates. BBB permeability was assessed by measuring EB content in brain tissue after transcardial perfusion and homogenization. Neurological function was assessed 24 h post-modeling using the Longa score, with a score greater than 1 indicating successful modeling. No significant neurological deficits were observed in the sham group, while all animals in the ICH group showed significant deficits (P < 0.0001). No differences in deficits were observed among the experimental groups (P > 0.05). Plasma EB concentration decreased over time in both the sham and ICH groups (P < 0.0001), with the tail vein group showing no significant change between 30 min and 2 h (P > 0.05), but a significant decrease at 24 h (P < 0.0001). At 30 min and 2 h, no significant differences in plasma EB concentration were observed between the sham and ICH jugular vein groups (P > 0.05), though the plasma concentration was significantly higher in the sham group at 24 h (P < 0.05). No significant differences in EB content were noted between ICH jugular vein group and ICH tail vein group groups at 30 min, 2 h, and 24 h in brain tissues (P > 0.05), although the ICH jugular vein group showed higher EB content than the sham group (P < 0.05). No significant differences were found between the ICH tail and sham groups at 2 and 24 h, though the distribution is more dispersed in the tail vein group. Additionally, the hemorrhagic side of the brain showed significantly higher EB content than the non-hemorrhagic side after 2 h (P < 0.05), but no difference was observed at 24 h. Jugular vein injection of EB dye provides a precise, reliable, and reproducible method for evaluating BBB integrity in mouse models of ICH. The tail vein injection method, when successful, can also serve as a valid alternative for BBB assessment. This technique offers significant advantages over other methods, contributing to more accurate BBB evaluations in cerebrovascular disease research.


  • Catechin-Based Polyphenol Nanoparticles Ameliorated Ferroptosis to Alleviate Brain Injury after Intracerebral Hemorrhage

    by Yu Zeng, Jian Liu, Zhuo Kong, Guoqiang Han, Yunbiao Xiong, Tao Luo, Liangzhao Chu, Peng Zhang, Dongxu Ma, Jinhai Lan, et al.

    Spontaneous intracerebral hemorrhagic stroke (ICH) is a highly aggressive disease, with a high incidence and mortality rate. Iron deposition following ICH leads to oxidative damage and motor dysfunction, significantly impacting the overall quality of life for those affected. Here, a polyphenolic nanomedicine, catechin-based polyphenol nanoparticles surface-modified by thiol-terminated poly(ethylene glycol) (CNPs@PEG), was developed through the oxidative polymerization and self-assembly of catechin, a natural compound in tea. Due to its potent antioxidant and metal-chelating properties, CNPs@PEG effectively maintained blood-brain barrier integrity, reduced brain edema, significantly increased the survival rate of mice with cerebral hemorrhage and markedly improved neurological deficits after ICH. Mechanistically, CNPs@PEG accomplishes this by chelating iron, enhancing tissue antioxidant capacity, reducing oxidative stress, and inhibiting iron deposition. This approach holds promise as a targeted therapeutic strategy for addressing cerebral hemorrhage and other conditions associated with iron overload.


  • Open Access

    Orexin‐A Attenuates the Inflammatory Response in Sepsis‐Associated Encephalopathy by Modulating Oxidative Stress and Inhibiting the ERK/NF‐κB Signaling Pathway in Microglia and Astrocytes

    by Jing Guo, Dexun Kong, Junchi Luo, Tao Xiong, Fang Wang, Mei Deng, Zhuo Kong, Sha Yang, Jingjing Da, Chaofei Chen, et al.

    Background: Oxidative stress‐induced inflammation is a major pathogenic mechanism in sepsis‐associated encephalopathy (SAE). We hypothesized that regulation of reactive oxygen species (ROS) by the neuropeptide orexin‐A could prevent SAE‐induced oxidative stress and inflammation. Therefore, the aim of this study was to investigate the effects of orexin‐A on oxidative stress and inflammation in SAE in mice.Methods: Adult male mice were treated with orexin‐A (250 μg/kg, intranasal administration) to establish a cecal ligation perforation (CLP) model. We performed behavioral tests, observed neuronal damage in the hippocampal region, measured the levels of ROS, NOX2, and observed the structure of mitochondria by transmission electron microscopy. We then examined the inflammatory factors TNF‐α and IL‐1β, the activation of microglia and astrocytes, the expression of ERK/NF‐κB, C3, and S100A10, and the presence of A1 type astrocytes and A2 type astrocytes.Results: Orexin‐A treatment improved cognitive performance in CLP‐induced SAE mice, attenuated neuronal apoptosis in the hippocampal region, ameliorated ROS levels and the extent of mitochondrial damage, and reduced protein expression of NOX2 in hippocampal tissue. In addition, orexin‐A treatment significantly reduced microglia and astrocyte activation, inhibited the levels of P‐ERK and NF‐κB, and reduced the release of IL‐1β and TNF‐α, which were significantly increased after CLP. Finally, Orexin‐A treatment significantly decreased the number of C3/glial fibrillary acidic protein (GFAP)‐positive cells and increased the number of S100A10/GFAP‐positive cells.Conclusion: Our data suggest that orexin‐A reduces ROS expression by inhibiting CLP‐induced NOX2 production, thereby attenuating mitochondrial damage and neuronal apoptosis. Its inhibition of microglial and A1‐type astrocyte activation and inflammation was associated with the ERK/NF‐κB pathway. These suggest that orexin‐A may reduce cognitive impairment in SAE by reducing oxidative stress‐induced inflammation.


  • Open Access

    Unraveling the genetic and molecular landscape of sepsis and acute kidney injury: A comprehensive GWAS and machine learning approach

    by Sha Yang, Jing Guo, Yunbiao Xiong, Guoqiang Han, Tao Luo, Shuo Peng, Jian Liu, Tieyi Hu, Yan Zha, Xin Lin, et al.